Published in Biochim Biophys Acta on February 22, 1991
Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res (2010) 2.60
Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein. J Biol Chem (2011) 1.83
CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res (2010) 1.79
Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. J Lipid Res (2008) 1.63
Disruption of the Arabidopsis CGI-58 homologue produces Chanarin-Dorfman-like lipid droplet accumulation in plants. Proc Natl Acad Sci U S A (2010) 1.31
Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease. Dermatoendocrinol (2011) 1.05
CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin action. Diabetes (2012) 1.04
Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis (2010) 0.90
Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders. Clin Dermatol (2012) 0.84
CGI-58 is an alpha/beta-hydrolase within lipid transporting lamellar granules of differentiated keratinocytes. Am J Pathol (2008) 0.82
Pathobiology of the stratum corneum. West J Med (1993) 0.81
Comparative gene identification-58/α/β hydrolase domain 5: more than just an adipose triglyceride lipase activator? Curr Opin Lipidol (2014) 0.80
Triglyceride metabolism in human keratinocytes cultured at the air-liquid interface. Arch Dermatol Res (1995) 0.75
Glycogen storage disease in adults. Ann Intern Med (1994) 3.58
Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr (2000) 3.11
Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem (1980) 3.06
Immunocytochemical localization of phytochrome. Proc Natl Acad Sci U S A (1971) 2.81
Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79
Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73
A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol (1970) 2.58
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J (1999) 2.46
Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol (1991) 2.41
Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med (1996) 2.36
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med (2005) 2.33
An immunochemical characterization of the phytochrome destruction reaction. Biochim Biophys Acta (1974) 2.20
Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A (2000) 2.14
Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J (2001) 2.12
Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry (1999) 2.04
Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest (1990) 2.02
Reversible redistribution of phytochrome within the cell upon conversion to its physiologically active form. Proc Natl Acad Sci U S A (1975) 2.01
A non-adrenergic inhibitory nervous pathway in guinea-pig trachea. Br J Pharmacol (1974) 1.97
The inducement of tone and its inhibition in isolated tracheal muscle. J Pharm Pharmacol (1971) 1.95
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest (1987) 1.95
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci U S A (1986) 1.91
Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol (1999) 1.90
Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS (2001) 1.90
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest (1992) 1.88
The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab (2001) 1.86
Selective changes in microsomal enzymes of triacylglycerol phosphatidylcholine, and phosphatidylethanolamine biosynthesis during differentiation of 3T3-L1 preadipocytes. J Biol Chem (1978) 1.86
Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake. Br J Pharmacol (1976) 1.77
Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology (1995) 1.77
Role of cytokines in inducing hyperlipidemia. Diabetes (1992) 1.74
Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol (2000) 1.73
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
Fat distribution and metabolic changes in patients with HIV infection. AIDS (1999) 1.67
Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem (2001) 1.64
Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J Biol Chem (2001) 1.64
Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res (1992) 1.64
AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63
Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis (2000) 1.59
Leptin directly alters lipid partitioning in skeletal muscle. Diabetes (1997) 1.57
IL-1 beta mediates leptin induction during inflammation. Am J Physiol (1998) 1.57
The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab (1993) 1.53
Regulation of insulin receptors and insulin responsiveness in 3T3-L1 fatty fibroblasts. Endocrinology (1979) 1.49
Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem (1996) 1.48
Electron microscopic localization of phytochrome in plants using an indirect antibody-labeling method. J Histochem Cytochem (1974) 1.47
Renal disease in type I glycogen storage disease. N Engl J Med (1988) 1.45
Role for circulating lipoproteins in protection from endotoxin toxicity. Infect Immun (1995) 1.42
Visceral adipose tissue: relationships between single slice areas at different locations and obesity-related health risks. Int J Obes (Lond) (2006) 1.42
"Selectivity" and "specificity": what do they mean? Gen Pharmacol (1993) 1.40
Inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet (1991) 1.40
Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA. Biochem J (1997) 1.39
The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem (2000) 1.39
Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology (1993) 1.37
Lipid topogenesis. J Lipid Res (1981) 1.36
Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest (1993) 1.36
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med (1996) 1.34
Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J Cell Sci (1983) 1.32
Receptor-mediated endocytosis of insulin: role of microvilli, coated pits, and coated vesicles. Proc Natl Acad Sci U S A (1982) 1.30
Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology (1992) 1.28
U-46619, a selective thromboxane A2-like agonist? [proceedings]. Br J Pharmacol (1980) 1.28
Neutral lipid storage disease with fatty liver and cholestasis. J Pediatr Gastroenterol Nutr (1997) 1.27
Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol. J Biol Chem (2001) 1.26
Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea. Prostaglandins (1985) 1.26
Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol (2000) 1.25
Contractile and relaxant actions of prostaglandins on guinea-pig isolated trachea. Br J Pharmacol (1980) 1.25
Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab (1993) 1.24
Sonography of the hand and foot in foreign body detection. J Ultrasound Med (1987) 1.23
Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis (1993) 1.23
Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr (1990) 1.22
Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phospholipid metabolism. J Lipid Res (1998) 1.22
Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol (1998) 1.21
Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol (1996) 1.20
Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res (1993) 1.20
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb (1992) 1.20
Tumor necrosis factor stimulates hepatic lipid synthesis and secretion. Endocrinology (1989) 1.19
Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol (1995) 1.19
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis (1998) 1.19
Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol (1998) 1.19
Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J Lipid Res (1996) 1.19
Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem (1996) 1.18
Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev (1996) 1.17
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14
Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discordant with protein expression. Arch Biochem Biophys (2001) 1.14
Immunolocalization of the secretory isoform of Na-K-Cl cotransporter in rat renal intercalated cells. J Am Soc Nephrol (1996) 1.13
Dynamic interplay of TFIIA, TBP and TATA DNA. J Mol Biol (1997) 1.13
The pharmacology of salmeterol. Life Sci (1993) 1.13
Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Br J Pharmacol (1993) 1.12
Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos (2000) 1.11
Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine. Methods Enzymol (1992) 1.11
Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Med (2008) 1.10
Independent effects of patch size and structural complexity on diversity of benthic macroinvertebrates. Ecology (2010) 1.10
Triglyceride-rich lipoproteins prevent septic death in rats. J Exp Med (1995) 1.09
Studies on the characterization of prostanoid receptors. Adv Prostaglandin Thromboxane Leukot Res (1983) 1.07
Body mass index as a phenotypic expression of adiposity: quantitative contribution of muscularity in a population-based sample. Int J Obes (Lond) (2009) 1.06
Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology (1989) 1.06
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J Clin Invest (1989) 1.06
Rat sn-glycerol-3-phosphate acyltransferase: molecular cloning and characterization of the cDNA and expressed protein. Biochim Biophys Acta (1999) 1.06
In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J Biol Chem (2001) 1.06
Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes (1999) 1.04